4U7Z
Mitogen-Activated Protein Kinase Kinase (MEK1) bound to G805
Summary for 4U7Z
Entry DOI | 10.2210/pdb4u7z/pdb |
Related | 1S9J 4U80 4U81 |
Descriptor | Dual specificity mitogen-activated protein kinase kinase 1, MAGNESIUM ION, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzimidazole-6-carboxamide, ... (5 entities in total) |
Functional Keywords | kinase, inhibitor, complex, transferase-transferase inhibitor complex, transferase/transferase inhibitor |
Biological source | Homo sapiens (Human) |
Cellular location | Cytoplasm, cytoskeleton, microtubule organizing center, centrosome: Q02750 |
Total number of polymer chains | 1 |
Total formula weight | 38917.81 |
Authors | Robarge, K.D.,Ultsch, M.H.,Wiesmann, C. (deposition date: 2014-07-31, release date: 2014-09-24, Last modification date: 2023-09-27) |
Primary citation | Robarge, K.D.,Lee, W.,Eigenbrot, C.,Ultsch, M.,Wiesmann, C.,Heald, R.,Price, S.,Hewitt, J.,Jackson, P.,Savy, P.,Burton, B.,Choo, E.F.,Pang, J.,Boggs, J.,Yang, A.,Yang, X.,Baumgardner, M. Structure based design of novel 6,5 heterobicyclic mitogen-activated protein kinase kinase (MEK) inhibitors leading to the discovery of imidazo[1,5-a] pyrazine G-479. Bioorg.Med.Chem.Lett., 24:4714-4723, 2014 Cited by PubMed: 25193232DOI: 10.1016/j.bmcl.2014.08.008 PDB entries with the same primary citation |
Experimental method |
Structure validation
Download full validation report![Download](/newweb/media/icons/dl.png)
![Download](/newweb/media/icons/dl.png)